SUMMARY In a stud) of 105 asymptomatic HBsAg positive blood donors, 9 (8-6 %) were found to have HBeAg, 38 (36-2 %) anti-HBe, and the remaining 58 (55-2 %) neither marker detectable by gel diffusion. There was no correlation between HBeAg/anti-HBe status and HBsAg sub-types, Glm allotypes, the presence of anti-Gm, red cell antibodies, or rheumatoid factor. Rheumatoid factor activity could be removed from anti-HBe positive sera without removing anti-HBe activity, indicating that separate entities were involved.
The possibility that the host genetic make-up may influence the type of response to human hepatitis B infection has led to a search for allotypic markers linked to certain types of response. For example, evidence has been presented for (Arndt-Hanser et al., 1974) and against (Rundle et al., 1975) an association between specific ABO blood groups and persistent hepatitis B surface antigen (HBsAg) carriage. In multiply transfused thalassaemic patients, Blumberg et al. (1972) described an association between the development of anti-HBs (that is, successful virus elimination) and the presence of both anti-Gm antibodies and relative homozygosity with respect to Gm immunoglobulin markers. Hillis et al. (1977) have reported a positive association between certain locus B HLA types and HBs antigenaemia in dialysis patients. Finally , it has been proposed that a tendency to HBsAg carriage after hepatitis B virus (HBV) infection may be inherited as a simple autosomal recessive gene (Blumberg et al., 1969) , although convincing evidence against this hypothesis in its simplest form has been presented (Vyas, 1974; Mazzur, 1976) .
Among chronic carriers of HBsAg, the additional presence of HBeAg (Magnius and Espmark, 1972 In addition, evidence was presented by Neurath and Strick (1977) that HBeAg itself may be an idiotypic IgG molecule and anti-HBe an anti-idiotype. However, more recent work (Takahashi et al., 1978) has shown that HBeAg activity can exist in serum as a molecule smaller than IgG, as well as in association with IgG. Nevertheless, the possibility that the HBeAg/anti-HBe system might be associated with the Gm system, or with naturally occurring rheumatoid factor, warranted investigation.
Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors
Methods
HBsAg was detected by reverse passive haemagglutination (RPHA, Wellcome) or radioimmunoassay (RIA, Abbott). Five of the 105 donors were positive by RIA but negative by RPHA. HBeAg and anti-HBe were detected by gel diffusion after threefold concentration of test sera; all positive results gave a line of identity with a positive control reaction, and gave no precipitin lines with negative control sera of groups AB and 0. Sera were tested for rheumatoid factor (RF) using different commercial kits by latex agglutination and a modified Waaler-Rose procedure (Searle, Hyland and Denver) in the two laboratories and discrepant results were re-tested. HBsAg subtyping was performed using solid phase radioimmunoassay and by radioimmunoprecipitation using monospecific antisera. Glm(a) and Glm(f) allotyping was performed by a passive haemagglutination inhibition technique (Vyas et al., 1968) using red cells coated with antiRh of appropriate Glm allotype. The screening for anti-Gm was carried out using a panel of cells coated with various anti-Rh sera known to detect most anti-Gm antibodies (M. M. Izatt, personal communication).
Results
HBeAg was found in 9 (8 6%) sera and anti-HBe in 38 (36 2%), while 58 (55 2%) sera showed neither reaction. Blood group A was less common (P < 0 05) in HBeAg positive donors than in the total carrier population, which itself showed ABO and Rhesus(D) blood group frequencies similar to those of the overall regional population (Table 1) . The percentage of carriers with HBeAg declined with age, whereas no age-specific trend was seen in anti-HBe frequency (Figure) . All (Tedder and Briggs, 1977; Furuta et al., 1977) , although an association between RF and antiHBe was reported in one study (Kacaki et al., 1977) . To examine formally the possibility that anti-HBe and RF recognised the same determinants on IgG molecules and were functionally identical, RF activity was removed from RF positive, anti-HBe positive sera by caprylic acid treatment or absorption with 5 mg/ml of denatured (750C for 15 min) pooled human gammaglobulin. Both treatments removed all detectable RF activity, while the reconcentrated treated sera contained anti-HBe in 2/2 sera after absorption with globulin, and in 1/3 sera after treatment with caprylic acid. These results provided further evidence that RF and anti-HBe activity were not related. 156 HBsAg carriers in West Germany (Biswas et al., 1978) , whereas the HBeAg rate was increased only from 2-6% to 3-6% with the more sensitive assay. It is therefore possible that the nine HBeAg positive donors detected by gel diffusion in our study represent nearly all those who would be detectable by a more sensitive assay, and that the majority of donors above with neither HBeAg nor anti-HBe detectable would prove to have low levels of anti-HBe. In Japanese HBsAg carriers, the HBeAg rate declined with age from 76-9 % in those aged 0-9 years to 9-5 % in those aged 50 or above, while a reciprocal increase in anti-HBe rate with age was seen . However, vertical transmission appears to play a much greater role in maintaining infection in Japan than in western Europe, introducing additional age-related factors. In a Frenchstudy of 329 HBsAg carriers, no effect of age on the HBeAg rate was seen, while the anti-HBe rate declined with age (Courouce-Pauty and Plancon, 1978) . As factors such as age of acquisition of infection, prevalence of various subtypes, varying transmission routes, and possible differences in life expectancy for those carriers who are HBeAg positive could conceivably influence HBeAg/antiHBe prevalence data, we cannot conclude from our age-related data that seroconversion from HBeAg to anti-HBe over a number of years commonly occurs in the natural history of the carrier state. In contrast, several workers have described seroconversion from HBeAg to anti-HBe positivity during most acute HBV infections (Frosner et al., 1978; Miyakawa and Mayumi, 1978) .
An association between blood group A and a lack of an HBeAg response has not to our knowledge been previously reported. We found no association be- Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors 135 tween HBeAg/anti-HBe status and Glm allotype or the presence of anti-Gm, red cell antibodies or rheumatoid factor. In contrast to Courouce-Pauty and Plangon (1978), we did not find a higher prevalence of HBeAg or anti-HBe in ad infections compared to ay infections. We were not able to compare adw and adr subtypes, which were found to be significantly different with respect to HBeAg/ anti-HBe in the French work. We were, however, able to show that subtype distribution was not related to age in our population, a correlation that was not examined in the French study.
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